Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes

Mitsuyoshi Takahara,1 Toshihiko Shiraiwa,2 Taka-aki Matsuoka,3 Kaoru Yamamoto,2 Yoshifumi Maeno,2 Yuka Shiraiwa,2 Yoko Yoshida,2 Naoto Katakami,4 Hiroaki Iijima,5 Hideyuki Katsumata,6 Kenji Arakawa,5 Toshio Hashimoto,5 Iichiro Shimomura3 1Department of Diabetes Care Medicine, Osaka University Gradua...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takahara M, Shiraiwa T, Matsuoka TA, Yamamoto K, Maeno Y, Shiraiwa Y, Yoshida Y, Katakami N, Iijima H, Katsumata H, Arakawa K, Hashimoto T, Shimomura I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
beta cell function
canagliflozin
glimepiride
glycemic control
type 2 diabetes mellitus
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/83540f3531f743f581e795fb20d708de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/83540f3531f743f581e795fb20d708de

Ejemplares similares